Long-term alterations in μ, δ and κ opioidergic receptors following middle cerebral artery occlusion in mice

Acta Neuropathologica

Volumn 114, Issue 5, 2007, Pages 491-500

  Boutin, Hervé ^a,c   Catherine, Armelle ^a   MacKenzie, Eric T ^a   Jauzac, Philippe ^a   Dauphin, François ^b  

^a GIP CYCERON   (France)

^b UNIVERSITÉ DE CAEN   (France)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Autoradiography; Brain ischemia; Histology; Opioid receptors; Ventral thalamic nuclei

Indexed keywords

BIOLOGICAL MARKER; DELTA OPIATE RECEPTOR; KAPPA OPIATE RECEPTOR; MU OPIATE RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BRAIN CORTEX; BRAIN INFARCTION; CELL DENSITY; CONTROLLED STUDY; CORRELATION ANALYSIS; HISTOPATHOLOGY; LATERAL RETICULAR NUCLEUS; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; STROKE; SUBSTANTIA NIGRA; THALAMUS LATERAL NUCLEUS;

ANIMALS; BINDING SITES; BIOLOGICAL MARKERS; BRAIN; BRAIN INFARCTION; BRAIN ISCHEMIA; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; DOWN-REGULATION; INFARCTION, MIDDLE CEREBRAL ARTERY; MICE; NERVE DEGENERATION; OPIOID PEPTIDES; RECEPTORS, OPIOID, DELTA; RECEPTORS, OPIOID, KAPPA; RECEPTORS, OPIOID, MU; TIME; TIME FACTORS;

EID: 34948907309     PISSN: 00016322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00401-007-0269-7     Document Type: Article

References (69)

1. Araki T, Murakami F, Kanai Y, Kato H, Kogure K (1993) Naloxone receptor binding in gerbil striatum and hippocampus following transient cerebral ischemia. Neurochem Int 23:319-325
2. Arvidsson U, Dado RJ, Riedl M, Lee J-H, Law PY, Loh HH, Elde R, Wessendorf MW (1995) δ-Opioid receptor immunoreactivity: distribution in brainstem and spinal cord, and relationship to biogenic amines and enkephalin. J Neurosci 15:1215-1235
3. Arvidsson U, Riedl M, Chakrabarti S, Lee J-H, Nakano AH, Dado RJ, Loh HH, Law P-Y, Wessendorf MW, Elde R (1995) Distribution and targeting of a μ-opioid receptor (MOR1) in brain and spinal cord. J Neurosci 15:3328-3341
4. Arvidsson U, Riedl M, Chakrabarti S, Vulchanova L, Lee J-H, Nakano AH, Lin X, Loh HH, Law P-Y, Wessendorf MW, Elde R (1995) The κ-opioid receptor is primarily postsynaptic: Combined immunohistochemical localization of the receptor and endogenous opioids. Proc Natl Acad Sci USA 92:5062-5066
5. Bemana I, Nagao S (1998) Effects of niravoline (RU 51599), a selective kappa-opioid receptor agonist on intracranial pressure in gradually expanding extradural mass lesion. J Neurotrauma 15:117-124
6. Benfenati F, Pich EM, Zoli M, Grimaldi R, Fuxe K, Agnati LF (1991) Changes in striatal μ and δ (opioid receptors after transient forebrain ischemia: A quantitative autoradiographic study. Brain Res 546:171-175
7. Birch PJ, Rogers H, Hayes AG, Hayward NJ, Tyers MB, Scopes DC, Naylor A, Judd DB (1991) Neuroprotective actions of GR89696, a highly potent and selective κ-opioid receptor agonist. Br J Pharmac 103:1919-1823
8. Bouet V, Freret T, Toutain J, Divoux D, Boulouard M, Schumann-Bard P (2006) Sensorimotor and cognitive deficits after transient middle cerebral artery occlusion in the mouse. Exp Neurol 203(2):555-567
9. Boutin H, Dauphin F, Jauzac Ph, MacKenzie ET (2000) Exofocal alterations in opioidergic receptor densities following focal cerebral ischaemia in mice. Exp Neurol 164:314-321
10. Boutin H, Dauphin F, MacKenzie ET, Jauzac Ph (1999) Differential time-course decreases in non-selective, mu, delta and kappa opioid receptors following focal cerebral ischemia in mice. Stroke 30:1271-1278
11. Boutin H, Dauphin F, MacKenzie ET, Jauzac Ph (1996) Cortical and subcortical alterations of the opioidergic system in response to cerebral ischaemia. In: Krieglstein J, Oberpichler-Schwenk H, Wissenschaftliche Verlagsgesellschaft (eds) Pharmacology of cerebral ischemia. Medpharm Scientific Publishers Stuttgart, Stuttgart, pp 601-617
12. Boutin H, Jauzac P, MacKenzie ET, Dauphin F (2003) Potential use of early alterations in mu and delta opioid receptors as a predictive index for delayed brain ischemic damage. Neurobiol Dis 13:63-73
13. Boutin H, Jauzac Ph, MacKenzie ET, Dauphin F (1998) Maximal densities of μ δ(and κ(receptors are differentially altered by focal cerebral ischaemia in the mouse. Brain Res 787:237-241
14. Chen TY, Goyagi T, Toung TJ, Kirsch JR, Hurn PD, Koehler RC, Bhardwaj A (2004) Prolonged opportunity for ischemic neuroprotection with selective kappa-opioid receptor agonist in rats. Stroke 35:1180-1185
15. Commons KG, Milner TA (1996) Cellular and subcellular localization of δ(opioid receptor immunoreactivity in the rat dentate gyrus. Brain Res 738:181-195
16. Commons KG, Milner TA (1997) Localization of delta opioid receptor immunoreactivity in interneurons and pyramidal cells in the rat hippocampus. J Comp Neurol 381:373-387
17. Dawson VL, Hsu CY, Liu TH, Dawson TM, Wamsley JK (1994) Receptor alterations in subcortical structures after bilateral middle cerebral artery infarction of the cerebral cortex. Exp Neurol 128:88-96
18. De Bilbao F, Guarin E, Nef P, Vallet P, Giannakopoulos P, Dubois-Dauphin M (2000) Cell death is prevented in thalamic fields but not in injured neocortical areas after permanent focal ischaemia in mice overexpressing the anti-apoptotic protein Bcl-2. Eur J Neurosci 12:921-934
19. Drake CT, Patterson TA, Simmons MI, Chavkin C, Milner TA (1996) Kappa Opioid receptor-like immunoreactivity in guinea pig brain: ultrastructural localization in presynaptic terminals in hippocampal formation. J Comp Neurol 370:377-395
20. Fernandez A, de Ceballos ML, Jenner P, Marsden CD (1994) Neurotensin, substance P, delta and mu opioid receptors are decreased in basal ganglia of Parkinson's disease patients. Neuroscience 61:73-79
21. Fried RL, Nowak TSJ (1987) Opioid peptide levels in gerbil brain after transient ischemia: Lasting depletion of hippocampal dynorphin. Stroke 18:765-770
22. Fujie W, Kirino T, Tomukai N, Iwasawa T, Tamura A (1990) Progressive shrinkage of the thalamus following middle cerebral artery occlusion in rats. Stroke 21:1485-1488
23. Galynker I, Schlyer DJ, Dewey SL, Fowler JS, Logan J, Gatley SJ, MacGregor RR, Ferrieri RA, Holland MJ, Brodie J, Simon E, Wolf AP (1996) Opioid receptor imaging and displacement studies with [6-O-[11 C]methyl]Buprenorphine in baboon brain. Nucl Med Biol 23:325-331
24. Gerfen CR, Wilson CJ (1996) Basal ganglia. In: Swanson LW, Björklund A, Hökfelt T (eds) Handbook of chemical neuroanatomy. Elsevier Science, Amsterdam, pp 371-468
25. Gracy KN, Svingos AL, Pickel VM (1997) Dual ultrastructural localization of μ-opioid receptors and NMDA-type glutamate receptors in the shell of the rat nucleus accumbens. J Neurosci 17:4839-4848
26. Guéniau C, Oberlander C (1997) The kappa opioid agonist niravoline decreases brain edema in the mouse middle cerebral artery occlusion model of stroke. J Pharmacol Exp Ther 282:1-6
27. Hansson P (2004) Post-stroke pain case study: Clinical characteristics, therapeutic options and long-term follow-up. Eur J Neurol 11 (Suppl 1):22-30:22-30
28. Hara H, Ayata G, Huang PL, Moskowitz MA (1997) Alteration of protein kinase C activity after transient focal cerebral ischemia in mice using in vitro [3 H]phorbol-12,13-dibutyrate binding autoradiography. Brain Res 774:69-76
29. Heiss WD, Herholz K (2006) Brain receptor imaging. J Nucl Med 47:302-312
30. Iizuka H, Sakatani K, Young W (1990) Neural damage in the rat thalamus after cortical infarcts. Stroke 21:790-794
31. Ikeda M, Mackay KB, Dewar D, McCulloch J (1993) Differential alterations in adenosine A1 and kappa 1 opioid receptors in the striatum in Alzheimer's disease. Brain Res 616:211-217
32. Itoh J, Ukai M, Kameyama T (1993) Dynorphin A-(1-13) potently prevents memory dysfunctions induced by transient cerebral ischemia. Eur J Pharmacol 234:9-15
33. Itoh J, Ukai M, Kameyama T (1993) U-50488H, a Kappa-opioid receptor agonist, markedly prevents memory dysfunctions induced by transient cerebral ischemia in mice. Brain Res 619:223-228
34. Jones AK, Watabe H, Cunningham VJ, Jones T (2004) Cerebral decreases in opioid receptor binding in patients with central neuropathic pain measured by [11C]diprenorphine binding and PET. Eur J Pain 8:479-485
35. Jones EG (ed) (1985) The thalamus. Plenum Press, New York
36. Kling MA, Carson RE, Borg L, Zametkin A, Matochik JA, Schluger J, Herscovitch P, Rice KC, Ho A, Eckelman WC, Kreek MJ (2000) Opioid receptor imaging with positron emission tomography and [18 F]cyclofoxy in long-term, methadone-treated former heroin addicts. J Pharmacol Exp Ther 295:1070-1076
37. Lehman A (ed) (1974) Atlas stéréotaxique du cerveau de la souris. CNRS, Paris
38. Loos M, Dihne M, Block F (2003) Tumor necrosis factor-alpha expression in areas of remote degeneration following middle cerebral artery occlusion of the rat. Neuroscience 122:373-380
39. Mackay KB, Kusumoto K, Graham DI, McCulloch J (1993) Focal cerebral ischemia in the cat: Pretreatement with a Kappa-1 opioid receptor agonist, CI-977. Brain Res 618:213-219
40. Mackay KB, Patel TR, Galbraith SL, Woodruff GN, McCulloch J (1996) The relationship between glutamate release and cerebral blood flow after focal cerebral ischaemia in the cat: Effect of pretreatment with enadoline (a kappa receptor agonist). Brain Res 712:329-334
41. 11 C]methyl)naltrindole and PET. Synapse 24:19-28
42. McLean S, Rothman RB, Herckenham M (1986) Autoradiographic localization of Mu and Delta opiate receptors in the forebrain of the rat. Brain Res 378:49-60
43. Miller L, Perry DC (1989) Opiate receptor subtype binding in gerbil hippocampus is altered by forebrain ischemia. Brain Res 495:367-372
44. Nagasawa H, Araki T, Kogure K (1994) Autoradiographic analysis of second-messenger and neurotransmitter receptor systems in the exo-focal remote areas of postischemic rat brain. Brain Res Bull 35:347-352
45. Nakane M, Teraoka A, Asato R, Tamura A (1992) Degeneration of the ipsilateral substantia nigra following cerebral infarction in the striatum. Stroke 23:328-332
46. Nordborg C, Johansson BB (1996) Secondary thalamic lesions after ligation of the middle cerebral artery: An ultrastructural study. Acta Neuropathol (Berl) 91:61-66
47. Robinson RG (1997) Neuropsychiatric consequences of stroke. Annu Rev Med 48:217-229
48. Rupalla K, Wiessner C, Allegrini P, Sauer D (1997) Characterization of immediate and delayed microglia activation and DNA fragmentation in different brain regions following permanent focal cerebral ischemia in mice. J Cereb Blood Flow Metab 17:S255
49. Saji H, Tsutsumi D, Magata Y, Iida Y, Konishi J, Yokoyama A (1992) Preparation and biodistribution in mice of [11C]carfentanil: A radiopharmaceutical for studying brain mu-opioid receptors by positron emission tomography. Ann Nucl Med 6:63-67
50. Scavini C, Rozza A, Bo P, Lanza E, Favalli L, Savoldi F, Racagni G (1990) κ-Opioid receptor changes and neurophysiological alterations during cerebral ischemia in rabbits. Stroke 21:943-947
51. 1-opioid receptors in the guinea pig dentate gyrus. J Neurophysiol 72:1697-1705
52. 11 C]methyl) naltrindole and positron emission tomography. J Cereb Blood Flow Metab 19:956-966
53. Sopala M, Frankiewicz T, Parsons C, Danysz W (2000) Middle cerebral artery occlusion produces secondary, remote impairment in hippocampal plasticity of rats - involvement of N-methyl- d -aspartate receptors? Neurosci Lett 281:143-146
54. Soriano MA, Ferrer I, Rodriguez-Farré E, Planas AM (1996) Apoptosis and c-Jun in the thalamus of the rat following cortical infarction. NeuroReport 7:425-428
55. Stumm R, Ruthrich H, Schulz S, Zhou C, Hollt V (2005) Expression of the mu-opioid receptor is induced in dentate gyrus granule cells after focal cerebrocortical ischaemia and stimulation of entorhinal afferents. Eur J Neurosci 22:1032-1044
56. Svingos AL, Cheng PY, Clarke CL, Pickel VM (1995) Ultrastructural localization of δ-opioid receptor and Met-enkephalin immunoreactivity in rat insular cortex. Brain Res 700:25-39
57. Svingos AL, Moriwaki A, Wang JB, Uhl GR, Pickel VM (1997) μ-Opioid receptors are localized to extrasynaptic plasma membranes of GABAergic neurons and their targets in the rat nucleus accumbens. J Neurosci 17:2585-2594
58. Svingos AL, Moriwaki A, Wang JB, Uhl GR, Pickel VM (1996) Ultrastructural immunocytochemical localization of μ-opioid receptors in rat nucleus accumbens: Extrasynaptic plasmalemmal distribution and association with Leu-enkephalin. J Neurosci 16:4162-4173
59. Tamura A, Tahira Y, Nagashima H, Kirino T, Gotoh O, Hojo S, Sano K (1991) Thalamic atrophy following cerebral infarction in the territory of the middle cerebral artery. Stroke 22:615-618
60. Ting P, Xu S, Krumins S (1994) Endogenous opioid system activity following temporary focal cerebral ischemia. Acta Neurochir 60(Suppl):253-256
61. Tyacke RJ, Robinson ES, Schnabel R, Lewis JW, Husbands SM, Nutt DJ, Hudson AL (2002) N1′-fluoroethyl-naltrindole (BU97001) and N1′-fluoroethyl-(14-formylamino)-naltrindole (BU97018) potential delta-opioid receptor PET ligands. Nucl Med Biol 29:455-462
62. VanBockstaele EJ, Commons K, Pickel VM (1997) Delta-opioid receptor is present in presynaptic axon terminals in the rat nucleus locus coeruleus: Relationships with methionine(5)-enkephalin. J Comp Neurol 575-586:388
63. Wagner JJ, Caudle RM, Chavkin C (1992) κ-Opioids decrease excitatory transmission in the dentate gyrus of the guinea pig hippocampus. J Neurosci 12:132-141
64. Waksman G, Hamel E, Delay-Goyet P, Roques BP (1987) Neutral endopeptidase-24.11, μ and δ opioid receptors after selective brain lesions: An autoradiographic study. Brain Res 436:205-216
65. Watanabe H, Kumon Y, Ohta S, Sakaki S, Matsuda S, Sakanaka M (1998) Changes in protein synthesis and calcium homeostasis in the thalamus of spontaneously hypertensive rats with focal cerebral ischemia. J Cereb Blood Flow Metab 18:686-696
66. 11C-diprenorphine binding in Huntington's disease: A comparison of region of interest analysis with statistical parametric mapping. J Cereb Blood Flow Metab 17:943-949
67. Welsh FA, Sakamoto T, McKee AE, Sims RE (1987) Effect of lactacidosis on pyridine nucleotide stability during ischemia in mouse brain. J Neurochem 49:846-851
68. Wevers A, Schmidt P, Cserpan E, cserpan I, Maderspach K, Staak M, Schröder H (1995) Cellular distribution of the mRNA for the κ-opioid receptor in the human neocortex: A non-isotopic in situ hybridization study. Neurosci Lett 195:125-128
69. Tyacke RJ, Robinson ES, Schnabel R, Lewis JW, Husbands SM, Nutt DJ, Hudson AL (2002) N1′-fluoroethyl-naltrindole (BU97001) and N1′-fluoroethyl-(14-formylamino)-naltrindole (BU97018) potential delta-opioid receptor PET ligands. Nucl Med Biol 29:455-462